Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Google Research is expanding tuberculosis screening tools based on chest X rays, cough audio and open models. Its technology supports clinical deployments in Africa and a national screening program in Indonesia.
Lunit and Summit Therapeutics will use the Lunit SCOPE IO pathology platform to analyze tumor tissue images for research involving ivonescimab.
Pathos AI raised $237 million in a Series E round led by Bristol Myers Squibb. The company will expand its Foundry AI platform and advance four oncology drug candidates.
BioVid has launched Mimetics, a research platform that models how physicians assess evidence and make treatment decisions. The company says validation tests found an 80% to 90% match between synthetic and human physician groups.
Draft NICE guidance recommends five AI tools for NHS use during a two year evidence collection period. The software highlights possible cancer on prostate MRI scans for review by radiologists.
Boehringer Ingelheim and Microsoft will study Digital Patient Twins for clinical development, starting with lung health.
The FDA has cleared AVIEW Aorta Metrics, which automatically segments the aorta and measures its diameter from chest CT images.
Ping An Good Doctor reported RMB 250 million in net profit for the first nine months of 2026, while its AI Doctor service reached nearly 13 million users.
BioStack raised $9.5 million in seed funding and launched a data network covering more than 100 million de identified patient records across four countries.
Former OpenAI science lead Kevin Weil launched Warp Sciences with $215 million in funding at an $865 million valuation. The startup will train robots to make and test compounds for drug discovery.
Tufts Medicine will use Humata Health to process prior authorization requests for select imaging services provided to Blue Cross Blue Shield of Massachusetts members.
Phylo will provide Bayer scientists with access to Biomni Lab for drug discovery workflows involving scientific literature, biomedical data and omics evidence.
Eko Health has launched the FDA cleared CORE 300 stethoscope, which combines analog listening with digital amplification, noise cancellation and optional AI analysis.
AgentixCare uses AI agents for clinical documentation, prior authorization, claims management and connected medical devices, with human review for critical actions.
Alethios adds tools for collecting participant reports, wearable data, digital biomarkers and laboratory results in remote health studies.
Tairex has introduced a system that coordinates 54 specialized AI doctors while physicians retain control over clinical decisions.
Genedata has integrated NVIDIA's RFD4-Proteina model into its biologics discovery workflows. Researchers can generate candidate binders, record laboratory results and use the findings to refine later designs.
NVIDIA and the UW Medicine Institute for Protein Design released RFD4-Proteina, while NVIDIA and Siemens Healthineers expanded work on adaptive radiotherapy.
Recovery Forecast predicts patient progress over 90 days and lets clinicians compare reassessment scores with the expected path.
Coherence Neuro raised $45 million to develop a brain implant that detects electrical signals linked to tumors and delivers stimulation intended to halt their growth.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
